Topics

OpenAngle Glaucoma Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975

01:50 EST 2 Feb 2020 | BioPortfolio Report Blog

FirstView Market Insight OpenAngle Glaucoma Market Review, Epidemiology And Market Forecast 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights.The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales trend and market revenue during study period 20182029.Glaucoma is an eye disease that gradually steals vision. There are typically no early warning signs or painful symptoms of openangle glaucoma. It develops slowly and sometimes without noticeable sight loss for many years.

Most people who have openangle glaucoma feel fine and do not notice a change in their vision at first because the initial loss of vision is of side or peripheral vision, and the visual acuity or sharpness of vision is maintained until late in the disease.

By the time a patient is aware of vision loss, the disease is usually quite advanced. Without proper treatment, glaucoma can lead to blindness.In openangle glaucoma, the angle in eye where the iris meets the cornea is as wide and open as it should be, but the eye's drainage canals become clogged over time, causing an increase in internal eye pressure and subsequent damage to the optic nerve. It is the most common type of glaucoma, affecting about four million Americans, many of whom do not know they have the disease.Overview

This report contains comprehensive overview of disease including disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends, as well as details about treatment algorithms and treatment guidelines

Epidemiology Forecast

This section encompasses information on the incidence and prevalence of disease in EU5, US Japan. It also provides historical, current and forecasted estimates of diagnosed/treatable patient population.

Existing and upcoming treatment landscape

Captures the evolution of treatment paradigm including the current and emerging drug therapies. Provides information on the clinical trial results, mechanism of action, route of administration, therapeutic positioning, regulatory milestones and patent exclusivity. It gives insight into the potential therapeutic targets for drug development. The section also covers major events and latest happenings, deals and collaborations.

Market Size

This section of report will address the major issues, on the size and total addressable market share. This will help the companies to understand and visualize their business prospects and make major decisions based on the historical, current and forecasted market share across the globe. Analyze the commercial potential of the product as well as the disease/therapy area.


Market Trends Unmet needs

This section of the report helps to understand the market trend and opportunities by analyzing the impact of current therapies on the market, current and future unmet needs, drivers and barriers and demand of better technology. This is determined by analyzing the impact of various factors such as mechanism of action, route, cost of therapy, patient segmentation, existing available treatments, compliance and need of the market, expected launch timelines, competitors, brand value and KOLs perception.


List of products

Betaadrenergic blockers.

Alpha2 Agonists, Ophthalmic.

Carbonic anhydrase inhibitors.

Antiglaucoma, Combos.

Miotic agents parasympathomimetics

Prostaglandin analogs.

Rho Kinase/Norepinephrine Transporter Inhibitor.

Hyperosmotic agents.

Original Article: OpenAngle Glaucoma Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975

NEXT ARTICLE

More From BioPortfolio on "OpenAngle Glaucoma Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...